Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
复制标题
大鼠黑质内注射 2-甲基-去甲哈曼(N-甲基-4-苯基吡啶鎓离子 (MPP) 的 β-碳啉类似物)后纹状体多巴胺能毒性。
DOI:
10.1016/0304-3940(89)90645-9
复制
发表时间:
1989
影响因子:
2.5
通讯作者:
Collins,MA
中科院分区:
文献类型:
--
作者:
Neafsey,EJ;Drucker,G;Raikoff,K;Collins,MA
Methylated β-carboline compounds are mammalian indole metabolites that we have proposed to be endogenous neurotoxins due to their structural similarity to MPP+, the active oxidized product of the dopaminergic toxin,N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Several laboratories have demonstrated that MPP+administration into the substantia nigra or median forebrain bundle of rats results in extensive depletion of striatal dopamine and its metabolites. We now report that three weeks after intranigral injection of the β-carboline, 2-methyl-norharman, striatal dopamine, DOPAC, and homovanillic acid (HVA) concentrations ipsilateral to the injection are reduced 41–64% compared to vehicle-injected controls; in individual animals dopamine depletions of 96% were achieved. In addition, at the 2-methylnorharman injection site in the substantia nigra, large lesions and gliosis were apparent under light microscopic examination. This is the first direct demonstration that a 2-methyl-β-carbolinium ion is neurotoxic. It lends further validity to the hypothesis that MPP+-like β-carbolines may be endogenous causative agents in Parkinson's disease.